Blood & Tissue
-
MoreARUP Laboratories
Efficiency keeps ARUP Laboratories an industry leader.
-
MoreTop 8 Obstacles in Pharma & Biologics Product Registration & Submission Management
Automation can help pharmaceutical and biologics companies along the path to a global product launch. This white paper identifies common problems with submissions and how best to address them.
-
MoreSoftware Automation in the Blood and Biologics Industry
This white paper explores the range of software solutions targeting organizations in the blood and biologics industry, from EDMS to QMS. Evaluate and select the most suitable solution for them.
-
MoreCompliance with FDA's Good Tissue Practices
This Q&A breaks down the key requirements of 21 CFR Part 1270 (Human Tissue Intended for Transplantation) and Part 1271 (Human Cells, Tissues, and Cellular Tissue-Based Products).
-
MoreMasterControl Registrations™ Toolkit for Pharma & Biologics Companies
MasterControl Registrations for eCTD is a cloud-based solution designed to streamline content generation and the collection and management of artifacts required for regulatory submission.
-
MoreCommon Reasons for FDA 483 Inspectional Observations in Biologics Manufacturing Environments
Learn about the most common 483 observations and audit findings, and avoid warning letters by staying compliant and addressing issues in the stipulated time period.
-
Loading More...
